CytomX Therapeutics Inc. Company Profile
NASDAQ: CTMXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.55-0.01 (-0.39%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 2.55 0.00%
CytomX Therapeutics at a glance
CytomX Therapeutics Inc. (NASDAQ: CTMX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. The company's shares have traded publicly since 2015. At a market capitalization of $557.8 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001501989, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- CytomX Therapeutics Inc.
- Ticker
- NASDAQ: CTMX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- United States
- IPO year
- 2015
- Market cap
- $557.82M
- SEC CIK
- 0001501989
Companies similar to CytomX Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MNPRMonopar Therapeutics Inc. | 83.78 | +5.29% | $562.35M | vs CTMX |
| PHATPhathom Pharmaceuticals Inc. | 6.81 | +0.44% | $550.94M | vs CTMX |
| CRMDCorMedix Inc. | 7.28 | 0.00% | $567.43M | vs CTMX |
| STTKShattuck Labs Inc. | 5.66 | -3.50% | $567.55M | vs CTMX |
| EVOEvotec SE ADR | 1.61 | -1.23% | $572.18M | vs CTMX |
| AQSTAquestive Therapeutics Inc. | 4.62 | +0.22% | $579.86M | vs CTMX |
| BLSMBlossomHill Therapeutics Inc. | 16.61 | -3.93% | $527.95M | vs CTMX |
| OCSOculis Holding AG | 8.50 | -2.52% | $523.50M | vs CTMX |